Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant SARS-CoV-2 Spike S1 antibody (HRP)

This Human Monoclonal antibody specifically detects SARS-CoV-2 Spike S1 in ELISA. It exhibits reactivity toward SARS Coronavirus-2 (SARS-CoV-2).
Catalog No. ABIN6953153

Quick Overview for Recombinant SARS-CoV-2 Spike S1 antibody (HRP) (ABIN6953153)

Target

See all SARS-CoV-2 Spike S1 Antibodies
SARS-CoV-2 Spike S1

Antibody Type

Recombinant Antibody

Fragment

scFv fragment

Reactivity

  • 45
  • 6
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
SARS Coronavirus-2 (SARS-CoV-2)

Host

  • 17
  • 10
  • 9
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Human

Clonality

  • 33
  • 8
  • 5
Monoclonal

Conjugate

  • 41
  • 3
  • 1
  • 1
This SARS-CoV-2 Spike S1 antibody is conjugated to HRP

Application

  • 46
  • 10
  • 8
  • 6
  • 5
  • 5
  • 4
  • 4
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
ELISA

Clone

H6
  • Characteristics

    Recombinant anti-SARS-CoV-2 spike Mouse ScFv is expressed from 293 cells (HEK293) with a human IgG1 Fc tag on C-terminal.
    Mouse scFv fusion with human IgG1 Fc
    AA 16-685

    Purification

    Affinity-chromatography

    Immunogen

    Recombinant Human Novel Coronavirus Spike glycoprotein (S) (16-685aa)

    Isotype

    IgG1
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    50 % Glycerol, 0.01M PBS, pH 7.4, 0.03 % Proclin 300

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C,-80 °C

    Storage Comment

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze
  • Target

    SARS-CoV-2 Spike S1

    Target Type

    Viral Protein

    Background

    Spike glycoprotein comprises two functional subunits responsible for binding to the host cell receptor (S1 subunit) and fusion of the viral and cellular membranes (S2 subunit). For many coronavirus (CoVs), S is cleaved at the boundary between the S1 and S2 subunits, which remain non-covalently bound in the prefusion conformation. The distal S1 subunit comprises the receptor-binding domain(s) and contributes to stabilization of the prefusion state of the membrane-anchored S2 subunit that contains the fusion machinery. S is further cleaved by host proteases at the so-called S2' site located immediately upstream of the fusion peptide in all CoVs. This cleavage has been proposed to activate the protein for membrane fusion via extensive irreversible conformational changes. However, different CoVs use distinct domains within the S1 subunit to recognize a variety of attachment and entry receptors, depending on the viral species. Endemic human coronaviruses OC43 and HKU1 attach via their S domain A to 5-N-acetyl-9-O-acetyl-sialosides found on glycoproteins and glycolipids at the host cell surface to enable entry into susceptible cells. MERS-CoV S uses domain A to recognize non-acetylated sialoside attachment receptors, which likely promote subsequent binding of domain B to the entry receptor, dipeptidyl-peptidase 4. SARS-CoV and several SARS-related coronaviruses (SARSr-CoV) interact directly with angiotensin-converting enzyme 2 (ACE2) via SB to enter target cells.

    Gene ID

    43740568

    UniProt

    P0DTC2
You are here:
Chat with us!